An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

When comparing the 2 forms of liver disease directly, patients with MASLD had a higher prevalence of kidney stones (2.8%) than those with MASH (1.7%). The researchers noted that the finding challenges ...

Background and Aim: Chronic viral infections such as human immunodeficiency virus and hepatitis C virus (HCV) may decrease tissue response to insulin, thereby causing insulin resistance. In addition, ...

What is Fatty Liver? Fatty liver, medically known as hepatic steatosis, occurs when there is an abnormal accumulation of fat ...

Table 1 reports the demographic, anthropometric, and metabolic characteristics of the 588 participants (347 males [59%] and 241 females) stratified by the degree of ultrasonographic liver steatosis.

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH), ...

Metabolic dysfunction–associated steatotic liver disease (MASLD) has become the most common liver disease worldwide, with a global prevalence of 32.4%. Its growth over the past three decades has ...

Liver steatosis is more prevalent than liver fibrosis in people with HIV, with significant risk factors including age, hypertension, and diabetes. Liver fibrosis prevalence is low, with integrase ...